CAT
Caterpillar Inc.
CAT's fundamentals are strong, but it looks expensive: trading at 24x earnings, above its usual 18x. Analysts expect strong earnings growth, though they disagree widely on how much.
HSHP
Himalaya Shipping Ltd.
There isn't enough reported data to score HSHP yet.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
HSHP Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Unavailable | |
| Weak |
HSHP's profitability is currently strong, but its balance sheet is weak. There isn't enough data to rate its revenue and cash flow.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
HSHP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $16.13 | — |
| Cheap | 14x | $16.08 | -0.3% |
| Current | 14x | $16.13 | — |
| Fair | 38x | $43.30 | +168% |
| Expensive | 188x | $212 | +1216% |
Historical ranges are pointers, not guarantees.
HSHP has the edge over CAT in the historical PE scenario, which offers more potential upside but is not a forecast.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
CAT has the edge over HSHP on the outlook, with more favorable earnings and revenue expectations.
HSHP Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong decline | |
| Decline | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect HSHP's earnings and revenue to decline, with profitability weakening.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
HSHP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.30 | +15% |
| Q2 2026 | $1.13 | +653% |
| Q4 2025 | $0.38 | -21% |
| Q4 2024 | $0.48 | +1100% |
| Q4 2023 | $0.04 | +$0.10 |
HSHP has the edge over CAT in the latest year-over-year earnings comparison.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT's operating margin was 20% last quarter, up 3.1 points from the same quarter a year ago.
HSHP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $87.3M | +68% |
| Q4 2025 | $80M | +16% |
| Q2 2025 | $51.9M | -5.3% |
| Q4 2024 | $68.8M | +87% |
HSHP has the edge over CAT in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 62% | +8.9 points |
| Q4 2025 | 60% | +20 points |
| Q2 2025 | 39% | N/A |
| Q4 2024 | 55% | N/A |
| Q2 2024 | 53% | N/A |
| Q4 2023 | 40% | N/A |
HSHP has the edge over CAT on profitability, with a higher operating margin.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
HSHP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2022 | -$15.5M | +$26.2M |
| Q2 2022 | -$14.9M | -$14.9M |
HSHP and CAT do not have enough comparable growth data to identify a winner.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over HSHP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
HSHP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.6% | +1.2M shares |
| 1 year | +7.6% | +3.3M shares |
HSHP has 47M diluted shares, up 7.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q2 2021 | — |
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over HSHP on leverage, with a lower net debt burden relative to earnings.
HSHP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 4.9x | High |
| Q4 2025 | 6.7x | High |
| Q2 2025 | 7.8x | High |
| Q4 2024 | 7.5x | High |
| Q4 2023 | 17.4x | High |
HSHP's net debt is about 4.9 years of its operating earnings (EBITDA), down from 17 years a year ago.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
HSHP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.4 | Neutral |
| Stochastic | 28.1 | Neutral |
HSHP's weekly RSI is 51 (neutral) and its Stochastic is 28 (neutral).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
HSHP PE vs Industrials Sector
| Metric | HSHP | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 24x | 41% below |
| PE % | 18 | 59 | 41 pts below |
HSHP has the edge over CAT on valuation relative to its sector.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
HSHP has stronger trend alignment. CAT is above 2 of 5 weekly averages versus HSHP above 2 of 4.
HSHP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $16.8 | 4% below |
| 20 week MA | $16.6 | 2.6% below |
| 50 week MA | $14.1 | 15% above |
| 100 week MA | $10.3 | 57% above |
HSHP has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 57% above its 100-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.
HSHP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $5.80 | $6.76 | +17% |
| 2024 | $6.76 | $4.85 | -28% |
| 2025 | $4.85 | $8.96 | +85% |
| 2026 YTD | $8.96 | $16.1 | +80% |
HSHP has the edge over CAT on returns for 2026, with the stronger performance.